1.
Dalle Carbonare L, Bertoldo F, Lo Cascio V. Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo [Internet]. 1 [cited 6Apr.2020];61(1):54-. Available from: https://www.reumatismo.org/index.php/reuma/article/view/reumatismo.2009.54